Total Payments
$3,994
2024 Payments
$1,240
Companies
23
Transactions
240
Medicare Patients
3,250
Medicare Billing
$303,721
Payment Breakdown by Category
Food & Beverage$3,839 (96.1%)
Education$155.00 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,839 | 238 | 96.1% |
| Education | $155.00 | 2 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $735.24 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $532.22 | 21 | $0 (2024) |
| Lilly USA, LLC | $487.31 | 30 | $0 (2024) |
| Novo Nordisk Inc | $454.09 | 29 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $348.15 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $324.80 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $240.23 | 15 | $0 (2024) |
| PFIZER INC. | $145.55 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $119.36 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $109.88 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,240 | 76 | ABBVIE INC. ($307.59) |
| 2023 | $1,397 | 79 | Astellas Pharma US Inc ($255.36) |
| 2022 | $1,043 | 63 | Lilly USA, LLC ($179.70) |
| 2021 | $314.66 | 22 | Lilly USA, LLC ($58.41) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Biological | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Biological | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,691 | 2,230 | $269,144 | $151,431 |
| 2022 | 13 | 1,390 | 2,011 | $260,287 | $138,202 |
| 2021 | 6 | 169 | 175 | $23,488 | $14,089 |
Total Patients
3,250
Total Services
4,416
Medicare Billing
$303,721
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 327 | 593 | $96,860 | $51,052 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 329 | 329 | $65,800 | $42,747 | 65.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 256 | 380 | $49,400 | $21,831 | 44.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 126 | 126 | $9,450 | $9,063 | 95.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 42 | 51 | $11,475 | $8,043 | 70.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 26 | 26 | $5,200 | $4,253 | 81.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $9,085 | $3,373 | 37.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 127 | 127 | $2,794 | $2,738 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 170 | 170 | $2,550 | $2,499 | 98.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 88 | 88 | $1,760 | $1,642 | 93.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,525 | $1,203 | 47.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 25 | $2,375 | $1,149 | 48.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 79 | $3,950 | $773.55 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 70 | 71 | $3,550 | $617.98 | 17.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 13 | $975.00 | $346.23 | 35.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 93 | $1,395 | $99.23 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 284 | 545 | $91,025 | $53,013 | 58.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 200 | 200 | $38,650 | $26,789 | 69.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 231 | 381 | $49,530 | $23,920 | 48.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 146 | 147 | $11,025 | $10,072 | 91.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 129 | 129 | $25,800 | $8,378 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 122 | 122 | $22,570 | $5,673 | 25.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 24 | 25 | $5,625 | $4,054 | 72.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 146 | 146 | $3,212 | $3,148 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 121 | $6,050 | $1,186 | 19.6% |
About Dr. Jared Mathews, MD
Dr. Jared Mathews, MD is a Family Medicine healthcare provider based in Cumberland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2018. The National Provider Identifier (NPI) number assigned to this provider is 1174017545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jared Mathews, MD has received a total of $3,994 in payments from pharmaceutical and medical device companies, with $1,240 received in 2024. These payments were reported across 240 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,839).
As a Medicare-enrolled provider, Mathews has provided services to 3,250 Medicare beneficiaries, totaling 4,416 services with total Medicare billing of $303,721. Data is available for 3 years (2021–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Cumberland, MD
- Active Since 06/19/2018
- Last Updated 07/07/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174017545
Products in Payments
- VRAYLAR (Drug) $263.75
- MOUNJARO (Drug) $244.26
- XARELTO (Drug) $240.23
- TRADJENTA (Drug) $227.96
- QULIPTA (Drug) $196.16
- Ozempic (Drug) $193.25
- Rybelsus (Drug) $181.88
- BEVESPI AEROSPHERE (Drug) $174.18
- BREZTRI (Drug) $160.13
- UBRELVY (Drug) $151.58
- EMGALITY (Drug) $133.48
- AIRSUPRA (Drug) $133.12
- Veozah (Drug) $119.53
- Kerendia (Drug) $119.36
- JARDIANCE (Drug) $117.84
- ELIQUIS (Drug) $112.73
- XIFAXAN (Drug) $85.60
- LINZESS (Drug) $79.92
- BELSOMRA (Drug) $78.44
- Nuedexta (Drug) $76.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cumberland
Dr. Gina La Prova, Md, MD
Family Medicine — Payments: $771,942
Family Medicine $771,942
Dr. Gary Wagoner, Md P A, MD P A
Family Medicine — Payments: $2,789
Family Medicine $2,789
Dr. Sharmila Matippa, M.d, M.D
Family Medicine — Payments: $2,596
Family Medicine $2,596
Dr. Alan Carlson, Md, MD
Family Medicine — Payments: $1,442
Family Medicine $1,442
Terry Williams, Md, MD
Family Medicine — Payments: $976.16
Family Medicine $976.16
Dr. Thomas Lingen, Md, MD
Family Medicine — Payments: $960.82
Family Medicine $960.82